Results 21 to 30 of about 42,056 (305)

CD47(low) status on CD4 effectors is necessary for the contraction/resolution of the immune response in humans and mice. [PDF]

open access: yesPLoS ONE, 2012
How do effector CD4 T cells escape cell death during the contraction of the immune response (IR) remain largely unknown. CD47, through interactions with thrombospondin-1 (TSP-1) and SIRP-α, is implicated in cell death and phagocytosis of malignant cells.
Vu Quang Van   +12 more
doaj   +1 more source

CD47 Expression in Non-Melanoma Skin Cancers and Its Clinicopathological Implications

open access: yesDiagnostics, 2022
CD47 is a cell surface molecule and regulates diverse cellular responses. CD47 is highly expressed in cancer cells and has potential as a therapeutic target and prognostic factor in cancer patients. The expression patterns of CD47 in basal cell carcinoma
Seongsik Bang   +8 more
doaj   +1 more source

CD47 Enhances Cell Viability and Migration Ability but Inhibits Apoptosis in Endometrial Carcinoma Cells via the PI3K/Akt/mTOR Signaling Pathway

open access: yesFrontiers in Oncology, 2020
Purposes: To measure expression levels of CD47 during endometrial carcinoma development, and to determine specific modulatory effects.Methods: CD47 expression levels in endometrial carcinoma tissues and adjacent tissues were analyzed using qRT-PCR.
Yun Liu   +6 more
doaj   +1 more source

Evaluation of CD47 in the Suppressive Tumor Microenvironment and Immunotherapy in Prostate Cancer

open access: yesJournal of Immunology Research, 2023
Background. CD47 has high levels of expression in malignant cancer cells, which binds to SIRP-α to release the “don’t eat me” signal and prevents mononuclear macrophages from phagocytosing the cells.
Qianqian Wang   +8 more
doaj   +1 more source

CD47 expression is critical for CAR T-cell survival in vivo

open access: yesJournal for ImmunoTherapy of Cancer, 2023
Background CD47 is an attractive immunotherapeutic target because it is highly expressed on multiple solid tumors. However, CD47 is also expressed on T cells.
Stephen Gottschalk   +8 more
doaj   +1 more source

Targeting CD47 [PDF]

open access: yesCirculation Research, 2007
See related article, pages 712–720 Thrombospondin-1 (TSP-1) is a homotrimeric glycoprotein with multiple functional domains that serves as a key mediator of a number of diverse cellular and physiologic processes.1 TSP-1 is the major component of the α granule of platelets.
David J, Kaczorowski, Timothy R, Billiar
openaire   +2 more sources

Extracellular Matrix Protein Tenascin C Increases Phagocytosis Mediated by CD47 Loss of Function in Glioblastoma. [PDF]

open access: yes, 2019
Glioblastomas (GBM) are highly infiltrated by myeloid-derived innate immune cells that contribute to the immunosuppressive nature of the brain tumor microenvironment (TME).
Gao, Peisong   +14 more
core   +2 more sources

Thrombospondin-1/CD47 interaction regulates Th17 and treg differentiation in psoriasis [PDF]

open access: yes, 2019
Accumulating evidence on the role of Thrombospondin-1 (TSP-1) in the immune response has emerged during the last years. In spite of the importance of TSP-1 not only as anti-angiogenic factor but also as an immunomodulatory molecule, studies on the ...
Calzada, María J.   +11 more
core   +2 more sources

Regulation of CD47 expression on CD14+ monocytes by interferon-α in PBC patients

open access: yesFrontiers in Immunology, 2023
BackgroundPrimary biliary cholangitis (PBC) is a chronic intrahepatic cholestatic autoimmune liver disease characterized by inflammatory injury of small and medium-sized bile ducts in the liver.
Xi Su   +8 more
doaj   +1 more source

The landscape overview of CD47-based immunotherapy for hematological malignancies

open access: yesBiomarker Research, 2023
Extensive clinical and experimental evidence suggests that macrophages play a crucial role in cancer immunotherapy. Cluster of differentiation (CD) 47, which is found on both healthy and malignant cells, regulates macrophage-mediated phagocytosis by ...
Hua Yang, Yang Xun, Hua You
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy